Neoantigen Peptide Vaccine Plus Pembrolizumab in Renal Cell Carcinoma
Clinical trial NCT07686744 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07686744
- Sponsor
- Jian Lin
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-01
- Primary completion
- 2029-01-01
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.